ASEP Medical Holdings Inc.
SEPSF
$0.06
$0.014732.45%
| Weiss Ratings | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.08 | |||
| Price History | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 32.45% | |||
| 60-Day Total Return | 9.09% | |||
| 90-Day Total Return | -7.69% | |||
| Year to Date Total Return | 116.61% | |||
| 1-Year Total Return | -55.02% | |||
| 2-Year Total Return | -85.00% | |||
| 3-Year Total Return | -78.25% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -60.00% | |||
| 52-Week Low % Change | 116.61% | |||
| Price | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.15 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Dec 18, 2024 | |||
| 52-Week High Price (Date) | Jul 09, 2024 | |||
| Valuation | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.78M | |||
| Enterprise Value | 11.39M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -45.03% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 26.09 | |||
| Price/Book (Q) | 0.59 | |||
| Enterprise Value/Revenue (TTM) | 63.19 | |||
| Price | $0.06 | |||
| Enterprise Value/EBITDA (TTM) | -4.99 | |||
| Enterprise Value/EBIT | -3.52 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 76.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 778 600 0509 | |||
| Address | 730 View Street Victoria, BC V8W 3Y7 | |||
| Website | asepmedical.com | |||
| Country | Canada | |||
| Year Founded | 2021 | |||
| Profitability | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,797.09% | |||
| Profit Margin | -1,899.66% | |||
| Management Effectiveness | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -11.31% | |||
| Return on Equity | -- | |||
| Income Statement | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 179.30K | |||
| Total Revenue (TTM) | 179.30K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 179.30K | |||
| EBITDA (TTM) | -2.27M | |||
| EBIT (TTM) | -3.22M | |||
| Net Income (TTM) | -3.41M | |||
| Net Income Avl. to Common (TTM) | -3.41M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 42.19% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | 54.55% | |||
| Balance Sheet | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 39.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 74.70K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 14.72M | |||
| Current Ratio (Q) | 0.043 | |||
| Book Value Per Share (Q) | $0.10 | |||
| Total Assets (Q) | 17.99M | |||
| Total Current Liabilities (Q) | 1.75M | |||
| Total Debt (Q) | 216.90K | |||
| Total Liabilities (Q) | 3.27M | |||
| Total Common Equity (Q) | 7.81M | |||
| Cash Flow | SEPSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -800.00 | |||
| Cash from Financing (TTM) | 633.80K | |||
| Net Change in Cash (TTM) | -184.60K | |||
| Levered Free Cash Flow (TTM) | 517.90K | |||
| Cash from Operations (TTM) | -817.50K | |||
